Status

In portfolio

Country(ies)

Morocco, Across Africa, Middle East

Sector

Deal Type

Growth

Investment Fund

Mediterrania Capital II

Date of Investment

May 2023
Laprophan

Laprophan is a Moroccan pharmaceutical company and nowadays stands out as one of the undisputed leaders in the manufacturing, distribution, import and export of pharmaceutical products.

The company distributes its own branded products and imported finished products from large international laboratories, providing patients and healthcare professionals with a wide range of medical drugs covering over 40 specialties.

Laprophan also exports products to more than 30 countries across Africa and the Middle East.